National Organization for Rare Disorders, Inc.
It is possible that the main title of the report Norrie Disease is not the name you expected. Please check the synonyms listing to find the alternate name(s) and disorder subdivision(s) covered by this report.
- Anderson-Warburg syndrome
- atrophia bulborum hereditaria
- episkopi blindness
- fetal iritis syndrome
- Norrie syndrome
- Whitnall-Norman syndrome
Related Disorders List
Information on the following diseases can be found in the Related Disorders section of this report:
Norrie disease is a rare X-linked disorder that occurs due to errors or disruption (mutations) of the NDP gene.
All males are affected by loss of vision present at birth or shortly thereafter. Additional symptoms may occur in some cases, although this varies even among individuals in the same family. Most affected individuals develop hearing (auditory) loss which is progressive of many years and some may exhibit cognitive abnormalities such as developmental delays or behavioral issues. Mental retardation may occur in some cases.
Several disorders can occur due to mutation of the NDP gene including persistent hyperplastic primary vitreous (PHPV), X-linked familial exudative vitreoretinopathy (X-linked-FEVR), and some cases of retinopathy of prematurity (ROP) and Coats disease. These disorders represent a spectrum of disease associated with the NDP gene. Each of these disorders can also occur secondary to mutations in other genes.
The main symptom of Norrie disease is a retinal degeneration which occurs in utero and results in blindness at birth (congenital) or early infancy. Visual failure in this disorder is characterized by the abnormal development of the retina, the thin layer of nerve cells that lines the back of the eyes (retina). The retina senses light and converts it into nerve signals, which are then relayed to brain through the optic nerve.
In Norrie disease, the retinas separate from the underlying, supporting tissue (retinal detachment). This causes a grayish-yellow mass to develop in the back of eye behind the lens that may be mistaken for a tumor (pseudoglioma). This mass consists of immature retinal cells and may be apparent a few days after birth or may not be noted until weeks or months later. This mass is located behind the pupils of the eyes so that the pupils appear white, a condition known as leukocoria or "cat's eye" reflex.
The eyes of affected children go through additional progressive changes. The lenses of the eyes of an affected infant may be initially clear. Eventually, clouding (opacity) of the front, clear portion of the eye through which light passes (cornea) may develop, a condition known as a cataract. In addition, as the disorder progresses, shrinking of the eyeballs (phthisis bulbi) may occur and is often apparent by ten years of age. Subsequently, the lenses are often completely covered by cataracts.
In addition, the eyes may be abnormally small (microphthalmia) at birth, the pupils may be widened (dilated) and the colored portion of the eyes (irises) may be underdeveloped (hypoplastic) and may stick to the lens (posterior synechiae) or may stick to the cornea (anterior synechiae). The space in the eye behind the cornea and in front of the iris (anterior chamber) may be abnormally shallow and the outflow tracts of the eye may be blocked (occluded), resulting in increased pressure with the eye (intraocular pressure) that may be extremely painful.
Most individuals with Norrie disease develop progressive hearing loss due to abnormalities in the vascular abnormalities in the cochlear (inner ear). Hearing loss usually begins in early childhood and may be mild at first and slowly progressive. By the third or fourth decade there may be significant functional loss but can usually be aide assisted. Speech discrimination is relatively well preserved. The development and severity of hearing loss varies greatly even among members of the same family. In some cases, hearing loss may not develop until adulthood.
Approximately 30-50 percent of individuals with Norrie disease may experience cognitive abnormalities including delays in reaching developmental milestones disproportional to vision loss. Some will show behavioral problems including psychosis, aggressive behavior and cognitive regression. Mental retardation has been reported in some cases. Dementia is rare but may occur in late adulthood.
Norrie disease has been associated with disease of the peripheral blood vessels in some cases. Patients have been reported with venous stasis ulcers. In more complex molecular genetic cases (NDP deletion), one can sometimes see other clinical features including seizures, growth failure, endocrine abnormalities or severe mental retardation.
Norrie disease is inherited as an X-linked recessive trait. X-linked recessive genetic disorders are conditions caused by an abnormal gene on the X chromosome. Females have two X chromosomes but one of the X chromosomes is "turned off" and all of the genes on that chromosome are inactivated. Females who have a disease gene present on one of their X chromosomes are carriers for that disorder. Carrier females usually do not display symptoms of the disorder because it is usually the X chromosome with the abnormal gene that is "turned off". A male has one X chromosome and if he inherits an X chromosome that contains a disease gene, he will develop the disease. Males with X-linked disorders pass the disease gene to all of their daughters, who will be carriers. A male cannot pass an X-linked gene to his sons because males always pass their Y chromosome instead of their X chromosome to male offspring. Female carriers of an X-linked disorder have a 25 percent chance with each pregnancy to have a carrier daughter like themselves, a 25 percent chance to have a non-carrier daughter, a 25 percent chance to have a son affected with the disease, and a 25 percent chance to have an unaffected son.
Investigators have determined that Norrie disease occurs due to mutations of the NDP gene located on the X chromosome (Xp11.4). Chromosomes, which are present in the nucleus of human cells, carry the genetic information for each individual. Human body cells normally have 46 chromosomes. Pairs of human chromosomes are numbered from 1 through 22 and the sex chromosomes are designated X and Y. Males have one X and one Y chromosome and females have two X chromosomes. Each chromosome has a short arm designated "p" and a long arm designated "q". Chromosomes are further sub-divided into many bands that are numbered. For example, "chromosome X" refers to band 11.4 on the short arm of the X chromosome. The numbered bands specify the location of the thousands of genes that are present on each chromosome.
The NDP gene contains instructions for the body's cells to make (encode) a protein known as Norrin. The exact role or function of Norrin is unknown. It is believed to be essential for the proper development of blood vessels (angiogenesis), especially those that supply blood to the retina and the cochlear. .
In rare cases, females (heterozygotes) who inherit a single copy of the disease gene for Norrie disease, disease traits on the X chromosome may not always be masked by the normal gene on the other X chromosome. As a result, these females may exhibit some of the symptoms associated with the disorder such as vision loss.
Norrie disease is a rare disorder that is fully expressed in males only. In rare cases, carrier females may display some symptoms of the disorder. The incidence and prevalence rates for Norrie disease are unknown. The disorder has been reported in all ethnic groups.
Symptoms of the following disorders can be similar to those of Norrie disease. Comparisons may be useful for a differential diagnosis.
Familial exudative vitreoretinopathy (FEVR) is a genetic disorder involving retinal detachment caused by retinal dysfunction or dysfunction of the blood vessel bearing tissue of the eye (choroids). These conditions disturb the outer blood-retinal barrier (retinal pigment epithelium; RPE) or inner blood-retinal barrier, allowing fluid to build up in the sub-retinal space. Under normal conditions, water flows from the vitreous cavity to the choroids. The direction of flow is influenced by the relative concentration of the choroids with respect to the vitreous and the RPE that actively pumps ions and water from the vitreous into the choroids. When there is an increase in the inflow of fluid or a decrease in the outflow of fluid from the vitreous cavity that overwhelms the normal compensatory mechanisms, fluid accumulates in the sub-retinal space leading to an exudative retinal detachment. Damage to the RPE prevents the pumping action of fluid. The X-linked form of this disorder (X-linked FEVR) may be caused by mutations in the Norrie disease gene (NDP).
Persistent hyperplastic primary vitreous (PHPV) is a developmental disorder affecting the eye that is present at birth (congenital). The disorder is characterized by abnormalities of certain eye structures and loss of vision. Specific symptoms include abnormally small eyes (microphthalmia), cataracts, and/or the formation of a white membrane or mass in the pupil area behind the lens of the eyes (leukocoria). This later feature causes the pupil to appear white when light reflects off it. In some cases of bilateral PHPV mutations of the NDP gene have been identified.
Retinoblastoma is an extremely rare malignant tumor that develops in the nerve-rich layers that line the back of the eyes (retina). It occurs most commonly in children under the age of three. The most typical finding associated with retinoblastoma is the reflection of light off a tumor behind the lens of the eye, which causes the pupil to appear white, the so called "cat's eye reflex" (leukocoria). In addition, the eyes may be crossed (strabismus). In some affected children, the eye(s) may become red and/or painful. The presence of a retinoblastoma may cause a rise in the pressure in the eyeball (glaucoma). Retinoblastoma may affect one eye (unilateral) or both eyes (bilateral). In most cases, retinoblastoma occurs spontaneously for no apparent reason (sporadic). (For more information on this disorder, choose "retinbolastoma" as your search term in the Rare Disease Database).
Retinopathy of prematurity (ROP) is a potentially blinding disease affecting the retinas in premature infants. The retinas are the light-sensitive linings of the insides of the eyes. In infants born prematurely, the blood vessels that supply the retinas are not yet completely developed. Although blood vessel growth continues after birth, these vessels may develop in an abnormal, disorganized pattern, known as ROP. In some affected infants, the changes associated with ROP spontaneously subside. However, in others, ROP may lead to bleeding, scarring of the retina, retinal detachment and visual loss. Even in cases in which ROP changes cease or regress spontaneously, affected children may have an increased risk of certain eye (ocular) abnormalities, including nearsightedness, misalignment of the eyes (strabismus), and/or future retinal detachment. The two major risk factors for ROP are a low birth weight and premature delivery. (For more information on this disorder, choose "retinopathy of prematurity" as your search term in the Rare Disease Database.)
Coats disease is a rare disorder characterized by abnormal development of the blood vessels of the nerve-rich membrane lining the eyes (retina). Affected individuals may experience loss of vision and detachment of the retina. In most cases, only one eye is affected (unilateral). However, in rare cases, both eyes may be affected (bilateral Coats disease). In these bilateral cases, one eye is affected more than the other (asymmetric Coats disease). Some cases of Coats disease have occurred due to mutations of the NDP gene. (For more information on this disorder, choose "Coats" as your search term in the Rare Disease Database.)
Lenz microphthalmia syndrome is an extremely rare inherited disorder characterized by abnormal small size of one or both eyes (unilateral or bilateral microphthalmos) and/or droopy eyelids (blepharoptosis), resulting in visual impairment. In rare cases, affected infants may exhibit complete absence of the eyes (anophthalmia). Most affected infants also exhibit developmental delay and mental retardation, ranging from mild to severe. Additional physical abnormalities are often associated with this disorder such as an unusually small head (microcephaly) and/or malformations of the teeth, ears, and/or fingers and/or toes (digits). The range and severity of findings may vary from case to case. Lenz microphthalmia syndrome, which is inherited as an X-linked recessive genetic trait, is fully expressed in males only. However, females who carry one copy of the disease gene (heterozygotes) may exhibit some of the symptoms associated with the disorder, such as an abnormally small head (microcephaly), short stature, and/or malformations of the fingers and/or toes. (For more information on this disorder, choose "Lenz microphthalmia" as your search term in the Rare Disease Database).
A diagnosis of Norrie disease is suspected based upon a detailed patient history, a thorough clinical evaluation, and identification of characteristic findings. There may be a family history supporting X-linked inheritance. A diagnosis may be confirmed by molecular genetic testing in which a mutation in the defective gene (NDP) is identified. Such testing is available through clinical testing labs (www.genetests.org).
The treatment of Norrie disease may require the coordinated efforts of a team of specialists. Pediatricians, specialists who assess and treat eye abnormalities (ophthalmologists), specialists who assess and treat hearing loss (audiologists), and other healthcare professionals may need to systematically and comprehensively plan an affected child's treatment.
The treatment of individuals with Norrie disease is directed toward the specific symptoms that are apparent in each individual. Surgery may be necessary to remove cataracts and reattach retinas. These efforts may prevent shrinkage of the eyeballs, but will not improve vision. Earlier in utero treatment has been reported as well as early vitrectomy in attempts to preserve vision.
Hearing aids may be of benefit for individuals with hearing loss and is usually successful into middle or late adulthood. When hearing is significantly impaired, a cochlear implant may be helpful . Other treatment is symptomatic and supportive.
Early intervention and appropriate specialized education is important in ensuring that children with Norrie disease reach their highest potential. Services that may be beneficial include special remedial or personalized education, other medical, social, and/or vocational services.
Genetic counseling is important for genetic risk assessment in family members.
Information on current clinical trials is posted on the Internet at www.clinicaltrials.gov. All studies receiving U.S. government funding, and some supported by private industry, are posted on this government web site.
For information about clinical trials being conducted at the NIH Clinical Center in Bethesda, MD, contact the NIH Patient Recruitment Office:
Tollfree: (800) 411-1222
TTY: (866) 411-1010
For information about clinical trials sponsored by private sources, contact:
Lewis RA. Norrie Disease. NORD Guide to Rare Disorders. Lippincott Williams & Wilkins. Philadelphia, PA. 2003:655-656.
Traboulsi EI. Ed. A Compendium of Inherited Disorders and the Eye. Oxford University Press. New York, NY. 2006:125-126.
Chamney S, McLoone E, Willoughby CE. A mutation in the Norrie disease gene (NDP) associated with familial exudative vitreoretinopathy. Eye (Lond). 2011 Dec;25(12):1658. doi: 10.1038/eye.2011.226. Epub 2011 Sep 30. PubMed PMID:21960066.
Drenser KA, Walsh MK, Capone A Jr, Trese MT, Luo CK. Preterm treatment of Norrie disease. Ophthalmology. 2011 Aug;118(8):1694-5; author reply 1695,1695.e1. PubMed PMID: 21813101.
Walsh MK, Drenser KA, Capone A Jr, Trese MT. Norrie disease vs familial exudative vitreoretinopathy. Arch Ophthalmol. 2011 Jun;129(6):819-20. PubMed PMID: 21670366.
Liu D, Hu Z, Peng Y, et al. A novel nonsense mutation in the NDP gene in a Chinese family with Norrie disease. Mol Vis. 2010 Dec 8;16:2653-8. PubMed PMID: 21179243; PubMed Central PMCID: PMC3002970.
Staopoli JF, Xinw, Sims KB. Co-segregation of Norrie disease and idopathic pulmonary hypertension in a family with a microdeletion of the NDP region. J Med Genet 2010;47:786-790.
Ye X, Smallwood P, Nathans J. Expression of the Norrie disease gene (Ndp) in developing and adult mouse eye, ear, and brain. Gene Expr Patterns. 2011 Jan-Feb;11(1-2):151-5. Epub 2010 Nov 3. PubMed PMID: 21055480; PubMed Central PMCID: PMC3061303.
Kiernan DF, Blair MP, Shapiro MJ. In utero diagnosis of Norrie disease and early laser preserves visual acuity. Arch Ophthalmol. 2010 Oct;128(10):1382. PubMed PMID: 20938020.
Chow CC, Kiernan DF, Chau FY, Blair MP, Ticho BH, Galasso JM, Shapiro MJ. Laser photocoagulation at birth prevents blindness in Norrie's disease diagnosed using amniocentesis. Ophthalmology. 2010 Dec;117(12):2402-6. PubMed PMID: 20619898.
Walsh MK, Drenser KA, Capone A Jr, Trese MT. Early vitrectomy effective for Norrie disease. Arch Ophthalmol. 2010 Apr;128(4):456-60. PubMed PMID: 20385941.
Nikopoulos K, Venselaar H, Collin RW, et al. Overview of the mutation spectrum in familial exudative vitreoretinopathy and Norrie disease with identification of 21 novel variants in FZD4, LRP5, and NDP. Hum Mutat. 2010 Jun;31(6):656-66. PubMed PMID: 20340138.
Riveiro-Alvarez R, Trujillo-Tiebas MJ, Gimenez-Pardo A, et al. Genotype-phenotype variations in five Spanish families with Norrie disease. Mol Vis. 2005;11:705-711.
Haplin C, Owen G, Gutierrez-Espeleta GA, Sims K, Rehm HL. Audiologic features of Norrie disease. Ann Oto Rhinol Laryngol. 2005;114:533-538.
Royer G, Hanein S, Raclin V, et al. NDP gene mutations in 14 French families with Norrie disease. Hum Mutat. 2003;22:499.
Rehm HL, Gutierrez-Espeleta GA, Garcia R, et al. Norrie disease gene mutation in a large Costa Rican kindred with a novel phenotype including venous insufficiency. Hum Mutat. 1997;9:420-428.
Sims KB, Irvine AR, Good WV. Norrie disease in a family with a manifesting female carrier. Arch Ophthalmol. 1997;115:517-519.
Meindl A, Lorenz B, Achatz H, et al. Missense mutations in the Norrie disease gene (NDP) associated with X-linked familial vitreoretinopathy. Nat Genet. 1995;5:180-183
Chen ZY, Hendriks RW, Jobling MA, et al. Isolation and characterization of a candidate gene for Norrie disease. Nat Genet. 1992 Jun;1(3):204-8.
Berger W, Meindl A, van de Pol TJ, et al. Isolation of a candidate gene for Norrie disease by positional cloning. Nat Genet. 1992;: 199-203.
Sims KB. Updated:July 23,2009 . NDP-Related Retinopathies. In: GeneReviews at GeneTests: Medical Genetics Information Resource (database online). Copyright, University of Washington, Seattle. 1997-20123. Available at http://www.genetests.org .
Roche O. Norrie disease. Orphanet encyclopedia, July 2005. Available at: http://www.orpha.net Accessed on:January 13, 2012.
McKusick VA., ed. Online Mendelian Inheritance in Man (OMIM). Baltimore. MD: The Johns Hopkins University; Entry No:310600; Last Update:3/3/10. Available at: http://omim.org/entry/310600 Accessed on:January 13, 2012.
Foundation Fighting Blindness
7168 Columbia Gateway Drive, Suite 100
Columbia, MD 21046
March of Dimes Birth Defects Foundation
1275 Mamaroneck Avenue
White Plains, NY 10605
111 E 59th St
New York, NY 10022-1202
1825 K Street NW, Suite 1200
Washington, DC 20006
Hearing Health Foundation
363 Seventh Avenue, 10th Floor
New York, NY 10016-3904
Retinitis Pigmentosa International
P.O. Box 900
Woodland Hills, CA 91365
Norrie Disease Association
P.O. Box 3244
Munster, MA 46321
National Association for Parents of Children with Visual Impairments (NAPVI)
P.O. Box 317
Watertown, MA 02272-0317
National Federation of the Blind
200 East Wells Street
at Jernigan Place
Baltimore, MD 21230
American Society for Deaf Children
800 Florida Avenue NE
Washington, DC 20002-3695
American Foundation for the Blind
2 Penn Plaza
New York, NY 10121
American Council of the Blind
2200 Wilson Boulevard
Arlington, VA 22201
National Association of the Deaf
8630 Fenton Street
Silver Springs, MD 20910
NIH/National Eye Institute
31 Center Dr
Bethesda, MD 20892-2510
Blind Children's Center
4120 Marathon Street
Los Angeles, CA 90029-3584
Genetic and Rare Diseases (GARD) Information Center
PO Box 8126
Gaithersburg, MD 20898-8126
PO Box 241956
Los Angeles, CA 90024
Let Them Hear Foundation
1900 University Avenue, Suite 101
East Palo Alto, CA 94303
American Academy of Audiology
11730 Plaza America Drive, Suite 300
Reston, VA 20190
Perkins School for the Blind
175 North Beacon Street
Watertown, MA 02472
National Consortium on Deaf-Blindness
The Teaching Research Institute
345 N. Monmouth Avenue
Monmouth, OR 97361
Hearing Loss Association of America
7910 Woodmont Avenue
Bethesda, MD 20814
For a Complete Report
This is an abstract of a report from the National Organization for Rare Disorders, Inc.® (NORD). Cigna members can access the complete report by logging into myCigna.com. For non-Cigna members, a copy of the complete report can be obtained for a small fee by visiting the NORD website. The complete report contains additional information including symptoms, causes, affected population, related disorders, standard and investigational treatments (if available), and references from medical literature. For a full-text version of this topic, see http://www.rarediseases.org/search/rdblist.html.
The information provided in this report is not intended for diagnostic purposes. It is provided for informational purposes only. NORD recommends that affected individuals seek the advice or counsel of their own personal physicians.
It is possible that the title of this topic is not the name you selected. Please check the Synonyms listing to find the alternate name(s) and Disorder Subdivision(s) covered by this report
This disease entry is based upon medical information available through the date at the end of the topic. Since NORD's resources are limited, it is not possible to keep every entry in the Rare Disease Database completely current and accurate. Please check with the agencies listed in the Resources section for the most current information about this disorder.
For additional information and assistance about rare disorders, please contact the National Organization for Rare Disorders at P.O. Box 1968, Danbury, CT 06813-1968; phone (203) 744-0100; web site www.rarediseases.org or email email@example.com
Last Updated: 1/19/2012
Copyright 1988, 1989, 1994, 1996, 2001, 2008, 2012 National Organization for Rare Disorders, Inc.
Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.